Deucravacitinib 6 Mg Tablets

6 Mg Tablets, Bottle

4.5 (154)

15,000

Deucravacitinib 6 mg Tablets is a selective TYK2 inhibitor used to treat moderate to severe plaque psoriasis. It works by suppressing IL-12 and IL-23 signaling pathways, reducing immune-mediated inflammation. Common side effects include upper respiratory tract infections, headache, and fatigue. Clinical monitoring for infections and immune status is advised during treatment.

Description

Deucravacitinib 6 mg Tablets

Information Deucravacitinib is an orally administered selective tyrosine kinase 2 (TYK2) inhibitordeveloped for immune-mediated diseases.

Mechanism of Action Deucravacitinib modulates immune signaling pathways.- Selectively inhibits TYK2- Suppresses IL-12 and IL-23 signaling- Reduces immune-mediated inflammation

Uses / Indications Used in dermatologic immune disorders.- Moderate to severe plaque psoriasis

Side Effects Generally well tolerated.- Upper respiratory tract infections- Headache- Fatigue

Warnings & Precautions Clinical monitoring advised.- Monitor for infections- Assess immune status

Conclusion Deucravacitinib offers targeted immune modulation with improved selectivity and safety.This information is intended for educational purposes only and should not replace clinicaljudgment. Treatment decisions must be made by qualified healthcare professionals

Contact Us

Info Table
Country of Origin Made in India
Brand name LuciDeucra
Composition Deucravacitinib 6 Mg
Manufacturer Lucius Pharma
Strength 6 mg
Form Tablet
Packing 30 Tablets
Vendor Info
Benefits
Reviews

Description

Deucravacitinib 6 mg Tablets

Information Deucravacitinib is an orally administered selective tyrosine kinase 2 (TYK2) inhibitordeveloped for immune-mediated diseases.

Mechanism of Action Deucravacitinib modulates immune signaling pathways.- Selectively inhibits TYK2- Suppresses IL-12 and IL-23 signaling- Reduces immune-mediated inflammation

Uses / Indications Used in dermatologic immune disorders.- Moderate to severe plaque psoriasis

Side Effects Generally well tolerated.- Upper respiratory tract infections- Headache- Fatigue

Warnings & Precautions Clinical monitoring advised.- Monitor for infections- Assess immune status

Conclusion Deucravacitinib offers targeted immune modulation with improved selectivity and safety.This information is intended for educational purposes only and should not replace clinicaljudgment. Treatment decisions must be made by qualified healthcare professionals

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Deucravacitinib 6 Mg Tablets”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Deucravacitinib 6 mg Tablet used for?
Deucravacitinib 6 mg Tablet is a selective TYK2 inhibitor used to treat moderate to severe plaque psoriasis and psoriatic arthritis, working by suppressing immune signaling pathways that drive inflammation.
It can reactivate a dormant, undiagnosed tuberculosis infection. A skin test is typically done beforehand, and treatment for latent TB may be needed before starting this medication.
Yes, it may increase the risk of lymphoma and other cancers, since it works by decreasing immune system activity. Discuss this risk with your doctor before starting treatment.
Report yellowing of the skin or eyes, upper right stomach pain, nausea, vomiting, or loss of appetite to your doctor immediately, as these can signal liver problems.
No, it controls symptoms but doesn’t cure the underlying condition. Continue taking it even if your skin improves, and don’t stop without talking to your doctor first.
Deucravacitinib 6mg Tablet is manufactured by Lucius Pharma under the brand LuciDeucra, supplied as 30 tablets per bottle, made in India, and classified as a prescription-only immune-modulating medication.

Related products